HIV drug resistance testing is an important part of treatment planning because the virus can develop changes that reduce the effectiveness of certain antiretroviral medicines. These tests help healthcare professionals identify resistance patterns and select treatment combinations that are more likely to control viral replication. Testing may be performed before starting therapy or when treatment is not working as expected. Understanding the role of resistance testing, viral load monitoring, and treatment history can help patients participate in informed discussions with their healthcare team and support appropriate long term HIV management and care decisions.
HIV treatment has changed significantly with the availability of effective antiretroviral therapy. However, HIV can develop genetic changes, known as mutations, that may reduce its sensitivity to certain medications. HIV drug resistance testing helps healthcare professionals understand whether these changes are present and how they may influence treatment planning. The results are considered alongside factors such as treatment history, viral load, overall health, and possible medication interactions.
HIV drug resistance testing examines the virus to identify mutations associated with reduced response to specific antiretroviral drugs. Genotypic resistance testing is commonly used and identifies genetic changes in the virus. In some situations, other forms of testing may also be considered by healthcare professionals.
Resistance testing can be useful before beginning HIV treatment, particularly when there is a possibility of transmitted drug resistance. It may also be recommended when a person's viral load remains detectable or increases while taking antiretroviral therapy. The timing of testing can be important because resistance patterns may become more difficult to detect after certain changes in medication use.
Key aspects of HIV drug resistance testing include:
A resistance test does not provide a complete treatment plan on its own. Healthcare professionals interpret the results together with laboratory findings, previous medications, adherence patterns, and other individual factors.
Treatment planning aims to create an antiretroviral regimen that can effectively suppress HIV replication. When resistance is identified, healthcare professionals may avoid medicines affected by specific mutations and consider other active treatment options. The goal is generally to maintain or achieve viral suppression while considering safety, convenience, and long term treatment needs.
For people already receiving treatment, a detectable viral load does not always mean drug resistance is present. Missed doses, medication interactions, absorption problems, or other factors can also affect treatment effectiveness. Healthcare professionals may review these issues before deciding whether a treatment change is necessary.
Important elements considered during treatment planning include:
Regular medical follow up remains important after a treatment regimen is selected. Viral load testing can help assess how well treatment is controlling HIV over time. Patients should avoid stopping or changing HIV medications without discussing the decision with a qualified healthcare professional, as this may affect treatment effectiveness and future resistance patterns. Informed treatment planning, appropriate testing, and continued monitoring can support individualized HIV care and long term management.